Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
J Trace Elem Med Biol ; 79: 127210, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37229983

ABSTRACT

BACKGROUND: Disorders of metal elements and platelet dysfunction are common in patients with trauma-induced coagulopathy (TIC). AIM: The aim of this study was to explore the potential role of plasma metal elements in platelet dysfunction in TIC. METHODS: Thirty Sprague-Dawley rats were divided into control, hemorrhage shock (HS) and multiple injury (MI) groups. At timepoints of 0.5 and 3 h after trauma and being documented as HS 0.5 h, HS3 h, MI 0.5 h or MI3 h, blood samples were harvested for inductively coupled plasma mass spectrometer, conventional coagulation function and thromboelastograph. RESULTS: The plasma zinc (Zn), vanadium (V) and cadmium (Ca) decreased initially in HS 0.5 h and recovered slightly in HS3 h, whereas their plasma concentrations continued to decrease from beginning till MI3 h (p < 0.05). In HS, plasma Ca, V and nickel were negatively correlated to the time taken to reach the initial formation (R), whereas R was positively correlated to plasms Zn, V, Ca and selenium in MI (p < 0.05). In MI, plasma Ca was positively correlated to maximum amplitude, and plasma V was positively correlated to platelet count (p < 0.05). CONCLUSION: The plasma concentrations of Zn, V and Ca appeared to contribute to platelet dysfunction in HS 0.5 h, HS3 h, MI 0.5 h and MI3 h, which were trauma type sensitive.


Subject(s)
Blood Coagulation Disorders , Shock, Hemorrhagic , Rats , Animals , Rats, Sprague-Dawley , Blood Coagulation Disorders/etiology
2.
Anal Bioanal Chem ; 415(18): 4401-4410, 2023 Jul.
Article in English | MEDLINE | ID: mdl-36786836

ABSTRACT

Polarized light microscopy (PLM) is a common but critical method for pharmaceutical crystallinity characterization, which has been widely introduced for research purposes or drug testing and is recommended by many pharmacopeias around the world. To date, crystallinity characterization of pharmaceutical solids is restricted to laboratories due to the relatively bulky design of the conventional PLM system, while little attention has been paid to on-site, portable, and low-cost applications. Herein, we developed a smartphone-based polarized microscope with an ultra-miniaturization design ("hand-held" scale) for these purposes. The compact system consists of an optical lens, two polarizers, and a tailor-made platform to hold the smartphone. Analytical performance parameters including resolution, imaging quality of interference color, and imaging reproducibility were measured. In a first approach, we illustrated the suitability of the device for pharmaceutical crystallinity characterization and obtained high-quality birefringence images comparable to a conventional PLM system, and we also showed the great promise of the device for on-site characterization with high flexibility. In a second approach, we employed the device as a proof of concept for a wider application ranging from liquid crystal to environmental pollutants or tissues from plants. As such, this smartphone-based hand-held polarized light microscope shows great potential in helping pharmacists both for research purposes and on-site drug testing, not to mention its broad application prospects in many other fields.


Subject(s)
Smartphone , Reproducibility of Results , Microscopy, Polarization/methods , Pharmaceutical Preparations
3.
Antioxidants (Basel) ; 12(1)2023 Jan 15.
Article in English | MEDLINE | ID: mdl-36671064

ABSTRACT

Homocysteine is an amino acid containing a free sulfhydryl group, making it probably contribute to the antioxidative capacity in the body. We recently found that plasma total homocysteine (total-Hcy) concentration increased with time when whole blood samples were kept at room temperature. The present study was to elucidate how increased plasma total-Hcy is produced and explore the potential physiological role of homocysteine. Erythrocytes and leukocytes were separated and incubated in vitro; the amount of total-Hcy released by these two kinds of cells was then determined by HPLC-MS. The effects of homocysteine and methionine on reactive oxygen species (ROS) production, osmotic fragility, and methemoglobin formation in erythrocytes under oxidative stress were studied. The reducing activities of homocysteine and methionine were tested by ferryl hemoglobin (Hb) decay assay. As a result, it was discovered that erythrocytes metabolized methionine to homocysteine, which was then oxidized within the cells and released to the plasma. Homocysteine and its precursor methionine could significantly decrease Rosup-induced ROS production in erythrocytes and inhibit Rosup-induced erythrocyte's osmotic fragility increase and methemoglobin formation. Homocysteine (but not methionine) was demonstrated to enhance ferryl Hb reduction. In conclusion, erythrocytes metabolize methionine to homocysteine, which contributes to the antioxidative capability under oxidative stress and might be a supplementary protective factor for erythrocytes against ROS damage.

4.
Pharmaceutics ; 16(1)2023 Dec 27.
Article in English | MEDLINE | ID: mdl-38258055

ABSTRACT

Nano/micromotors are artificial robots at the nano/microscale that are capable of transforming energy into mechanical movement. In cancer diagnosis or therapy, such "tiny robots" show great promise for targeted drug delivery, cell removal/killing, and even related biomarker sensing. Yet biocompatibility is still the most critical challenge that restricts such techniques from transitioning from the laboratory to clinical applications. In this review, we emphasize the biocompatibility aspect of nano/micromotors to show the great efforts made by researchers to promote their clinical application, mainly including non-toxic fuel propulsion (inorganic catalysts, enzyme, etc.), bio-hybrid designs, ultrasound propulsion, light-triggered propulsion, magnetic propulsion, dual propulsion, and, in particular, the cooperative swarm-based strategy for increasing therapeutic effects. Future challenges in translating nano/micromotors into real applications and the potential directions for increasing biocompatibility are also described.

5.
Front Pharmacol ; 12: 725362, 2021.
Article in English | MEDLINE | ID: mdl-34776952

ABSTRACT

The poor bioavailability and rapid metabolism of curcumin (CUR) restrict its clinical application. Piperine (PIP), which was extracted from natural compounds, can increase the plasma concentration of curcumin in humanidad. As an artificial synthetic piperine analog, silepcimide (ILE) has significant advantages because of the low price and simple synthesis process. In this study, a simple and rapid HPLC-UV method was developed for determination of the plasma concentration of CUR, PIP,ILE and dihydrocurcumin (DHC, a metabolite of CUR) simultaneously. Meanwhile, the effects of PIP and ILE on the plasma concentration and pharmacokinetics of DHC in SD rats was studied to explore whether ILE could serve as a CUR bioavailability enhancer. The metabolic pathway of CUR was studied by comparing the differences of CUR plasma concentration between intravenous injection and oral administration over the same time period, and reacting with small intestine homogenate without microbes of SD rats. The results of drug-time curve showed that combined administration of ILE and CUR had significant effect on plasma concentrations of DHC. Repeated administration of PIP or ILE could significantly increase the plasma concentration of DHC. Plasma CUR could be detected in the samples of from intravenous injection of CUR rats, whereas, it couldn't be detected in the plasma sample form oral administration rats. CUR incubated with intestinal homogenate without intestinal bacteria could not be transformed into DHC. In conclusion, our results show that ILE can improve the bioavailability of CUR. Additionally, it was inferred that most of the CUR was reduced to DHC by NADPH when it was absorbed from gastrointestinal tract, and our results demonstrated that this pathway might be mediated by gastrointestinal microorganisms.

6.
Shock ; 55(1): 121-127, 2021 01 01.
Article in English | MEDLINE | ID: mdl-32433211

ABSTRACT

BACKGROUND: Our previous study demonstrated the types of platelet dysfunction varied at early stage (∼3 h) in trauma-induced coagulopathy (TIC) caused by different types of injuries. And arachidonic acid (AA)-dependent pathway inhibition in platelet seemed to be specific for TIC caused by multiple injury (MI). The aim of this research was to further study AA-dependent pathway inhibition in platelets in a rat model of TIC caused by MI and to explore its potential mechanisms. METHODS: Sprague-Dawley rat model of TIC caused by MI was established. We used thrombelastography with platelet mapping as a measure of platelet function to assess the inhibitory extent of AA-dependent activation pathway. Flow cytometry was used to determine the expression of activation-dependent granular protein P-selectin (CD62P). In addition, the plasma levels of 6-Keto-prostaglandin F1 alpha (6-Keto-PGF1α), Prostaglandin E2, and Thromboxane B2 were assessed by enzyme-linked immuno sorbent assay. RESULTS: The inhibition rate of AA-dependent pathway after injury was significantly higher than that of control. The maximum amplitude decreased in the MI group, compared with that of control. The percentage of CD62P expression in the MI group was remarkably lower than that of control after AA treatment. The plasma concentrations of 6-Keto-PGF1α and PGE2 increased in the MI group. CONCLUSION: Platelets inhibition was observed in TIC caused by MI at early stage after injury, which might be partially attributed to AA-dependent activation pathway dysfunction. The increase of plasma Prostacyclin and PGE2 levels may contribute to the inhibition process.


Subject(s)
Arachidonic Acid/metabolism , Blood Coagulation Disorders/blood , Blood Coagulation Disorders/etiology , Multiple Trauma/blood , Multiple Trauma/complications , Platelet Activation/physiology , 6-Ketoprostaglandin F1 alpha/blood , Animals , Blood Platelets , Dinoprostone/blood , Disease Models, Animal , Epoprostenol/blood , Male , P-Selectin/blood , Platelet Function Tests , Rats , Rats, Sprague-Dawley , Thrombelastography , Thromboxane B2/blood
7.
Biomed Chromatogr ; 34(8): e4845, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32267542

ABSTRACT

An ultra-high performance liquid chromatography tandem mass spectrometry method was developed for determination of homocysteine (HCY) in human plasma. The HCY was derivatized with 2-chloro-1-methylquinolinium tetrafluoroborate and isolated using solid-phase extraction. Derivatization, isolation and detection procedures were optimized. Satisfactory linearity was obtained with determination coefficients (r2 ) >0.999. The intra- and inter-day precisions were in the interval of 1.2-5.1% and accuracy was within ±7%. Mean recoveries were close to 100%. The limit of detection and the limit of quantification were 0.46 and 1.38 µmol/L, respectively. The method was then applied to investigate the relationship between plasma HCY and whole blood 5-methyltetrahydrofolate levels in healthy volunteers. The results revealed that the plasma level of HCY was significantly negatively correlated to whole blood 5-methyltetrahydrofolate in volunteers.


Subject(s)
Chromatography, High Pressure Liquid/methods , Homocysteine/blood , Tandem Mass Spectrometry/methods , Tetrahydrofolates/blood , Adult , Drug Stability , Female , Humans , Limit of Detection , Linear Models , Male , Reproducibility of Results , Young Adult
8.
Injury ; 51(6): 1312-1320, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32093941

ABSTRACT

BACKGROUND: Traumatic coagulopathy is a major public health issue globally with undefined mechanisms. We established rat models of hemorrhagic shock (HS), multiple injury (MI) and traumatic brain injury (TBI) to investigate the diversity of traumatic coagulopathy, especially platelet dysfunction. METHODS: Seventy male SD rats were divided randomly into seven groups(n = 10): control, HS30min, HS3h, MI30min, MI3h, TBI30min and TBI3h. Plasma or whole blood was collected for conventional coagulation tests, thromboelastography and platelet mapping. X-ray, 7T magnetic resonance imaging and hematoxylin-eosin staining of injured tissues were conducted to confirm the injuries of rats model. RESULTS: The activated partial thromboplastin time (aPTT) prolonged significantly in HS30min and MI3h groups, compared with those in control (P = 0.0403 and P = 0.0076, respectively). R values decreased in HS30min and HS3h groups, compared with those in control (P < 0.0001 and P < 0.0001, respectively). The maximum amplitude (MA) were 71.8 ± 0.6 mm, 71.9 ± 0.5 mm, 71.8 ± 0.7 mm, 70.0 ± 0.7 mm, 72.6 ± 0.9 mm, 70.4 ± 0.9 mm in HS30min, HS3h, MI30min, MI3h, TBI30min and TBI3h groups respectively, which were lower than those in control (P = 0.0304, P = 0.0205, P = 0.0431, P = 0.0007 and P = 0.0066, respectively). The platelet counts were 539±46 × 109/L, 523±31 × 109/L, 629 ± 18 × 109/L and 636±20 × 109/L in HS30min, HS3h, MI3h and TBI3h groups respectively, which were lower than those in control (P = 0.0040, P = 0.0001, P = 0.0127 and P = 0.0232, respectively). The adenosine diphosphate (ADP) inhibition rate decreased in HS30min group, compared with that in control (P = 0.0355). While, ADP inhibition rate increased in HS3h and TBI3h groups (P = 0.0041 and P = 0.0433 vs. control, respectively). The arachidonic acid (AA) inhibition rate increased in MI30min and MI3h groups, compared with control (P = 0.0029 and P = 0.0185, respectively). CONCLUSION: These results demonstrated that it might be the failure of forming a strong clot instead of the prolonged clot time, which contributed to traumatic coagulopathy. The platelet dysfunctions might contribute to trauma-induced coagulopathy in different ways. The loss of platelets might be the main reason for HS-induced coagulopathy. While, AA-dependent pathway inhibition might account for MI-induced coagulopathy. ADP-dependent pathway inhibition might be the major contributor for TBI-induced coagulopathy.


Subject(s)
Adenosine Diphosphate/analogs & derivatives , Arachidonic Acid/antagonists & inhibitors , Blood Coagulation Disorders/etiology , Brain Injuries, Traumatic/complications , Multiple Trauma/complications , Shock, Hemorrhagic/complications , Adenosine Diphosphate/blood , Animals , Arachidonic Acid/blood , Blood Coagulation Disorders/blood , Blood Coagulation Tests , Blood Platelets/physiology , Brain Injuries, Traumatic/blood , Disease Models, Animal , Male , Multiple Trauma/blood , Platelet Function Tests/adverse effects , Rats , Rats, Sprague-Dawley , Risk Assessment , Shock, Hemorrhagic/blood , Thrombelastography
9.
Pharmacology ; 104(5-6): 244-257, 2019.
Article in English | MEDLINE | ID: mdl-31494659

ABSTRACT

BACKGROUND/AIMS: Hydrazone and acylhydrazone derivatives, which are produced from aldehyde reacting with hydrazine or acylhydrazine, have been reported to exhibit antitumor activities. However, the angionenic effects of this kind of derivatives haven't been elucidated. Here, we synthesized 12 pyridoxal hydrazone and acylhydrazone compounds and investigated their antiangiogenic effects and the underlying mechanisms. METHOD: 3-(4,5-Dimethylthiazol-2-yl)-2, 5-dipheyltetrazolium bromide assay was used to screen the inhibitory effects of the synthesized compounds on endothelial cells (ECs) proliferation. The compound with best inhibitory effect was further evaluated with wound-healing assay and tube formation assay. Calcein-Am assay was carried out to determine the content of intracellular labile iron pool (LIP). Intracellular reduced glutathione (GSH) was determined by spectrophotometry. Flow cytometry was used to determine cell cycle and apoptosis. RESULTS: Compound 10 (3-hydroxy-5-[hydroxymethyl]-2-methyl-pyridine-4-carbaldehyde-2-naphthalen-1-acetyl hydrazone) showed the best inhibitory effect on human umbilical vascular ECs proliferation, with IC50 value of 25.4 µmol/L. It not only inhibited wound-healing and tube formation of ECs, but also decreased the content of intracellular LIP and GSH. Furthermore, it arrested ECs cycle at S phase and induced cell apoptosis. CONCLUSIONS: Compound 10 exhibits antiangiogenic effects by reducing the content of intracellular LIP and GSH, and subsequently arresting cell cycle and inducing cell apoptosis.


Subject(s)
Angiogenesis Inhibitors/chemical synthesis , Angiogenesis Inhibitors/pharmacology , Human Umbilical Vein Endothelial Cells/drug effects , Hydrazones/chemical synthesis , Hydrazones/pharmacology , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Glutathione/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/physiology , Humans , Wound Healing/drug effects
10.
Biol Trace Elem Res ; 192(2): 116-122, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30771140

ABSTRACT

Copper (Cu) and zinc (Zn) are involved in inflammatory process. This study was to investigate the clinical significance of Cu and Zn homeostasis alterations in acute appendicitis (AA). One hundred twenty-two AA patients and 102 healthy controls were enrolled in this study. Of which, 85 patients' appendixes were collected after appendectomy. Another six appendixes from colon cancer patients were collected as tissue controls. The contents of Cu and Zn in serum or appendix were detected, and the Cu to Zn ratio (CZr) was calculated. The concentrations of serum ceruloplasmin (CP), Cu/Zn superoxide dismutase (SOD1), interleukin-6 (IL-6), and interleukin-22 in serum were measured, as well as the activity of CP and SOD1. The serum Zn concentration and SOD1 activity, appendix contents of Cu and Zn significantly decreased in AA patients, compared with those of controls, while serum CZr, concentrations of CP, SOD1, and IL-6, as well as CP activity increased significantly in AA patients. Additionally, serum concentrations of Zn, CP, CZr, or SOD1 activity varied in different pathological types of AA. Indicators such as serum SOD1 activity might serve as predictors for pathological classification before surgery. The serum Zn and CZr may be helpful for diagnosis of pure AA. The Cu and Zn homeostasis was altered in AA patients, which might contribute to inflammatory process of AA.


Subject(s)
Appendicitis/blood , Copper/blood , Homeostasis , Zinc/blood , Acute Disease , Adult , Female , Humans , Male
11.
Medicine (Baltimore) ; 97(24): e11137, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29901643

ABSTRACT

Copper homeostasis can be altered by inflammation. This study aimed to investigate the alteration of serum copper homeostasis and to explore its clinical significance in patients with chronic hepatitis B (CHB).Thirty-two patients with CHB and 10 aged- and sex-matched healthy controls were recruited. Analyses included serum levels of total copper (TCu), copper ions (Cu), small molecule copper (SMC), ceruloplasmin (CP), Cu/Zn superoxide dismutase 1 (SOD1), urinary copper, and the activities of serum CP and SOD1.The serum TCu and urinary copper levels in patients with CHB were significantly higher than the controls (P = .04 and .003), while the serum Cu was lower than the controls (P = .0002). CP and SOD1 activities in the serum were significantly lower in patients with CHB compared to controls (P = .005) despite higher serum concentrations. In addition, serum alanine aminotransferase inversely correlated with serum CP activity (P = .0318, r = -0.4065).Serum copper homeostasis was altered in this cohort of patients with CHB. The results suggest increased oxidative stress and impaired antioxidant capability in patients with CHB, in addition to necroinflammation. These results may provide novel insights into the diagnosis and treatment of patients with CHB.


Subject(s)
Antioxidants/metabolism , Copper/blood , Hepatitis B, Chronic/blood , Homeostasis/physiology , Oxidative Stress/physiology , Adult , Ceruloplasmin/metabolism , Copper/urine , Female , Hepatitis B, Chronic/physiopathology , Humans , Male , Middle Aged , Superoxide Dismutase/blood
12.
Biol Trace Elem Res ; 185(1): 56-62, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29322430

ABSTRACT

This study was to investigate the alterations of serum copper homeostasis after hypertensive intracerebral hemorrhage (ICH), which is not yet clear. We recruited 85 hypertensive ICH patients and determined their serum levels of total copper (TCu), small molecule copper (SMC), and ceruloplasmin (Cp). Sera from 32 healthy persons and 12 primary hypertension patients were collected and analyzed as well. Serum TCu levels in ICH patients were tested at three time points (on admission, day 3, and day 7) and found to be higher than that in hypertension patients (p < 0.05). The serum SMC levels in hypertension patients and ICH patients at three time points were higher than that in healthy controls (p < 0.05). Higher serum SMC levels on days 3 and 7 were associated with death in the hospital. Additionally, higher serum SMC levels on the seventh day were associated with poor outcome at discharge. High serum Cp levels on admission, as well as low serum Cp levels on the seventh day, were associated with death in the hospital (p = 0.002 and p = 0.034, respectively). Our findings indicated that declines in serum Cp and increases in serum SMC are correlated with lethal or poor outcome in hypertensive ICH patients, possibly as a result of contributions to secondary injury of brain after hemorrhage due to impairment of iron transport and enhanced oxidative stress.


Subject(s)
Ceruloplasmin/metabolism , Copper/blood , Intracranial Hemorrhage, Hypertensive/blood , Intracranial Hemorrhage, Hypertensive/pathology , Aged , Female , Humans , Hypertension/blood , Male , Middle Aged , Oxidative Stress/physiology
13.
Ren Fail ; 40(1): 85-91, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29299951

ABSTRACT

Administration of mannitol with high dose could induce extensive isometric renal proximal tubular vacuolization and acute renal failure in clinic. We previously demonstrated that mannitol-induced human kidney tubular epithelial cell (HK-2) injury. The objective of our present work was to further study the cytotoxicity of mannitol in HK-2 cells and its potential mechanism. Cell viability was assessed by an MTT method. Cell morphological changes were observed. Furthermore, levels of malondialdehyde (MDA) and glutathione (GSH) were measured. Flow cytometry was performed to determine cell apoptosis by using Annexin V-FITC and PI. In addition, the F-actin of cells was labeled by FITC-Phalloidin for observation of cytoskeleton. The MTT assay displayed that the cell viability decreased significantly in a dose- and time-dependent manner. The morphological changes were observed, including cell membrane rapture and cell detachment. The GSH concentration in HK-2 cells decreased dramatically in mannitol treatment group, while MDA content increased significantly. The results of flow cytometry indicated that apoptotic percentages of HK-2 cells increased in 250 mmol/L mannitol treatment group. After treatment with 250 mmol/L mannitol for 48 h, HK-2 cells showed disorganization of cytoskeleton and even exhibited a totally destroyed cytoskeleton. Therefore, high dose of mannitol has a toxic effect on renal tubular epithelial cells, which might be attributed to oxidative stress, destroyed cellular cytoskeleton and subsequent cell apoptosis.


Subject(s)
Cell Survival/drug effects , Diuretics, Osmotic/pharmacology , Epithelial Cells/drug effects , Kidney Tubules, Proximal/drug effects , Mannitol/pharmacology , Acute Kidney Injury/chemically induced , Apoptosis/drug effects , Cell Line , Cell Membrane/drug effects , Cell Membrane/pathology , Cytoskeleton/drug effects , Cytoskeleton/pathology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Flow Cytometry , Glutathione/metabolism , Humans , Kidney Tubules, Proximal/cytology , Malondialdehyde/metabolism , Oxidative Stress/drug effects
14.
Eur J Pharmacol ; 793: 76-81, 2016 Dec 15.
Article in English | MEDLINE | ID: mdl-27840192

ABSTRACT

Angiogenesis has become an attractive target for cancer therapy since the US Food and Drug Administration (FDA) approved the first angiogenesis inhibitor (bevacizumab) for the treatment of metastatic colorectal cancer in 2004. In following years, a large number of angiogenesis inhibitors have been discovered and developed, ranging from monoclonal antibodies, endogenous peptides, to small organic molecules and microRNAs. Many of them are now entering the clinical trial, or achieving approval for clinical use. However, major limitations have been observed about angiogenesis inhibitors by continued clinical investigations, such as resistance, enhancing tumor hypoxia and reducing delivery of chemotherapeutic agents, which might be the main reason for poor improvement in overall survival after angiogenesis inhibitor administration in clinic. Therefore, optimal anti-angiogenic therapy strategies become critical. The present review summarizes recent researches in angiogenesis inhibitors, and proposes a perspective on future directions in this field.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Neoplasms/drug therapy , Angiogenesis Inhibitors/therapeutic use , Animals , Antineoplastic Agents/therapeutic use , Blood Vessels/drug effects , Blood Vessels/physiopathology , Humans , Neoplasms/blood supply
15.
Ann Clin Lab Sci ; 46(4): 346-52, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27466292

ABSTRACT

Dysregulation of copper (Cu) metabolism interrupts neuron function, and subsequently results in neuron degeneration, necrosis, and gliocyte hyperplasia. To further explore the effects of hippocampal Cu concentration on learning and memory, Sprague-Dawley (SD) rats were given once-daily intraperitoneal injections of Copper(II) acetate (Cu(OAc)2) at doses of 0.2, 2, or 20mg/Kg over 5 days. Ultrasonic oscillation dialysis was used to determine the free Cu by graphite furnace atomic absorption spectrometry (GFAAS). Cu administration induced a dose-dependent increase in total hippocampal Cu. However, free hippocampal Cu was found to increase only at the lower concentration of Cu(OAc)2 (0.2 mg/Kg) but decrease at higher concentrations of Cu(OAc)2 (2 and 20 mg/Kg). Higher doses of Cu(OAc)2 (2-20mg/Kg) decreased superoxide dismutase-1 (SOD1) activity, increased both malondialdehyde (MDA) levels and the glutamate/γ-aminobutyric acid (Glu/GABA) ratio, and impaired spatial cognition. However, the lower dose of Cu(OAc)2 (0.2 mg/Kg) showed the opposite effects. This biphasic effect might be attributed to free hippocampal Cu levels and corresponding alterations of Glu/GABA ratio and SOD1 activity.


Subject(s)
Copper/pharmacology , Maze Learning/drug effects , Memory/drug effects , Animals , Copper/administration & dosage , Dialysis , Graphite , Hippocampus/drug effects , Hippocampus/metabolism , Malondialdehyde/metabolism , Neurotransmitter Agents/metabolism , Rats, Sprague-Dawley , Spectrophotometry, Atomic , Superoxide Dismutase/metabolism , gamma-Aminobutyric Acid/metabolism
16.
Eur J Pharmacol ; 779: 138-46, 2016 May 15.
Article in English | MEDLINE | ID: mdl-26968484

ABSTRACT

Hydralazine (HYD), an old routine clinical anti-hypertension drug, is rarely used in clinic nowadays. Since the strategy of repositioning old drugs was put forward, HYD has been reported to possess various biological activities, including antitumor efficacy and reducing intra-tumor microvessel. Here, we investigated that whether HYD had the ability of anti-angiogeneis and its underlying mechanism. Cells proliferation, wound-healing, Transwell migration and invasion, tube formation and rat aortic ring assays in vitro and chicken chorioallantoic membrane (CAM) model in vivo were designed to investigated HYD's anti-angiogenic effect. Levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were assessed by enzyme-linked immune sorbent assay (ELISA). Hepatocellular carcinoma (HCC) mice model was used to evaluate HYD's effect on tumor growth and microvessel density. Our results showed that HYD not only inhibited human umbilical vascular endothelial cell (HUVEC) proliferation, wound-healing, Transwell migration and invasion and tube formation, but also suppressed the microvessel outgrowth of rat aortic ring in vitro and the neovascularzation of CAM in vivo. Furthermore, we demonstrated that HYD attenuated tumor angiogenesis and tumor growth. In the co-culture system of Transwell migration, the secretion of VEGF and bFGF was reduced by HYD respectively. In sum, our data indicate that HYD has the pharmacological effect of ant-angiogenesis by interference with VEGF and bFGF signaling pathways in endothelial cells. These findings suggest that HYD might be a promising angiogenesis inhibitor and a potential effective therapeutic agent for cancer therapy.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Hydralazine/pharmacology , Angiogenesis Inhibitors/therapeutic use , Animals , Cell Movement/drug effects , Cell Proliferation/drug effects , Fibroblast Growth Factor 2/metabolism , Gene Expression Regulation/drug effects , Hep G2 Cells , Humans , Hydralazine/therapeutic use , Mice , Neovascularization, Pathologic/drug therapy , Neovascularization, Physiologic/drug effects , Rats , Tumor Necrosis Factor-alpha/metabolism , Vascular Endothelial Growth Factor A/metabolism
17.
J Stroke Cerebrovasc Dis ; 25(1): 214-9, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26573522

ABSTRACT

BACKGROUND: Copper is a strong pro-oxidant. The most important pro-oxidative form in serum is small molecule copper (SMC), which is copper that is loosely bound to small molecules, such as amino acids and polypeptides. The association between copper and atherosclerotic diseases has been confirmed, but that between SMC and cerebral ischemic stroke (CIS), one of the most principal manifestations and causes of death of atherosclerotic disease, is not yet clear. METHODS: We recruited 45 CIS patients and 25 age- and gender-matched healthy controls. We detected their serum levels of SMC, total copper, homocysteine (Hcy), and ceruloplasmin (CP), as well as urinary total copper, and analyzed the relationship of SMC with these aforementioned metabolites or compounds in CIS patients. RESULTS: SMC was 4.2 ± .5 µg/L and 2.1 ± .9 µg/L; total copper in sera was 1345.5 ± 308.2 µg/L and 1180.3 ± 134.0 µg/L; and total copper in urine was 27.6 ± 9.3 µg/L and 18.8 ± 8.1 µg/L in patients and controls, respectively (all P < .05). Serum CP activity in CIS patients was 59.92 ± 12.11 U/L versus 37.76 ± 5.71 U/L in controls (P = .0001). The concentration of SMC was positively correlated with CP activity, Hcy concentration in sera, and urinary total copper. CONCLUSION: The serum level of SMC and total copper is remarkably elevated, and SMC positively correlates with Hcy, CP activity, and urinary total copper in CIS patients.


Subject(s)
Brain Ischemia/blood , Copper/blood , Adult , Aged , Blood Chemical Analysis/instrumentation , Brain Ischemia/urine , Case-Control Studies , Ceruloplasmin/analysis , Copper/urine , Dialysis/instrumentation , Female , Homocysteine/blood , Humans , Male , Middle Aged , Ultrasonics/instrumentation
18.
Clin Lab ; 60(4): 543-51, 2014.
Article in English | MEDLINE | ID: mdl-24779288

ABSTRACT

BACKGROUND: The determination of copper (Cu) in human blood is important in medical diagnosis. However, its biological activities strongly depend on the chemical forms, and thus data for total Cu concentration is not sufficient for medical diagnosis or mechanism study. Therefore, analyses of copper species in serum have much more physiologically meaningful. METHODS: Ultrasonic oscillation dialysis procedure was introduced in the determination of "free" Cu, more precisely PBS dialysis Cu (DiaCu), and exchangeable Cu (EXCu) by graphite furnace atomic absorption spectrometry (GFAAS). Then the levels of serum "free" Cu and EXCu from hepatitis, liver cancer, and cervical cancer patients were determined. RESULTS: The accuracy of the method ranged from 92% - 97% for PBS DiaCu and 90% - 107% for EXCu when using a dialysis membrane pore size of 25 kDa. The regression equation of the calibration curve was expressed as y = bChi + a, with linear regression coefficients (r2) of 0.9999 for ultrapure water and 0.9998 for PBS buffer and EDTA buffer. The limit of detection is 0.76 microg/L. Application of this method to serum samples showed that the levels of"free" Cu and EXCu in serum changed in various pathophysiological conditions. CONCLUSIONS: Ultrasonic oscillation dialysis-GFAAS method described here for the speciation of "free" Cu and EXCu in serum is simple with good reproducibility and small sample volume.


Subject(s)
Blood Chemical Analysis/methods , Copper/blood , Adult , Dialysis , Female , Hepatitis/blood , Humans , Liver Neoplasms/blood , Middle Aged , Spectrophotometry, Atomic , Ultrafiltration , Ultrasonics , Uterine Cervical Neoplasms/blood
19.
Cell Immunol ; 283(1-2): 61-9, 2013.
Article in English | MEDLINE | ID: mdl-23850964

ABSTRACT

Vascular adhesion protein-1 (VAP-1) is both an endothelial adhesion molecule involved in leukocytes emigration, and an oxidase belonging to the family of semicarbazide-sensitive amine oxidases (SSAOs). The enzyme activity of VAP-1 plays an important role in the migration of myeloid-derived suppressor cells (MDSCs) into tumor site, and SSAO inhibitors can block the function of VAP-1. The effects of SSAO inhibitors on leukocyte infiltration and tumor progression were evaluated in H22 hepatocellular carcinoma-bearing C57BL/6 mice. Tumor weight and volume were measured after SSAO inhibitor treatment. Then, MDSCs recruitment and neo-angiogenesis were determined using immunostaining. SSAO inhibitors significantly blocked the catalytic activity of VAP-1 in tumor, attenuated tumor progression, and reduced neo-angiogenesis. CD11b(+) and Gr-1(+) MDSCs, which normally infiltrate into tumors, were significantly diminished in tumor-bearing mice treated with SSAO inhibitors. The present study demonstrated that SSAO inhibitors might have an anti-tumor effect on hepatocellular carcinoma by inhibiting recruitment of CD11b(+) and Gr-1(+) cells and hindering angiogenesis, which could be attributed to impairing the catalytic activity of VAP-1.


Subject(s)
Amine Oxidase (Copper-Containing)/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Animals , Blotting, Western , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Immunohistochemistry , Mice , Mice, Inbred C57BL
20.
Biol Trace Elem Res ; 154(2): 268-74, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23780468

ABSTRACT

Significant changes of copper homeostasis were triggered by lipopolysaccharides, which result in systemic inflammatory response and contribute to hepatic injury. Administration of lipopolysaccharides resulted in the increase of plasma "free" copper and total copper concentrations, whereas, the decrease of "free" copper and total copper contents in liver tissue. Copper-associated proteins were detected and showed a down-regulation of X-linked inhibitor of apoptosis protein, and up-regulation of copper metabolism domain containing 1 and copper transporter 1. The alteration of these proteins would lower the apoptotic threshold. Meanwhile, the increasing of circulation copper might cause oxidative injury through Fenton reaction and contribute to tissue injury. Our findings underscored the possibility that these changes in systemic copper homeostasis might provide a novel insight of the characteristic of the acute phase of inflammatory response and the underlying influence on tissue injury.


Subject(s)
Adaptor Proteins, Signal Transducing/biosynthesis , Cation Transport Proteins/biosynthesis , Copper/metabolism , Lipopolysaccharides/toxicity , Liver/metabolism , Up-Regulation/drug effects , Animals , Copper Transporter 1 , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/pathology , Liver/pathology , Mice , Mice, Inbred BALB C , Rabbits , X-Linked Inhibitor of Apoptosis Protein/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...